DK156069C - Anvendelse af tert.butylaminsaltet af clavulansyre som mellemprodukt ved fremstillingen af clavulansyre og farmaceutisk tolerable salte og estere deraf - Google Patents

Anvendelse af tert.butylaminsaltet af clavulansyre som mellemprodukt ved fremstillingen af clavulansyre og farmaceutisk tolerable salte og estere deraf

Info

Publication number
DK156069C
DK156069C DK363080A DK363080A DK156069C DK 156069 C DK156069 C DK 156069C DK 363080 A DK363080 A DK 363080A DK 363080 A DK363080 A DK 363080A DK 156069 C DK156069 C DK 156069C
Authority
DK
Denmark
Prior art keywords
clavulanic acid
tert
esters
preparation
tolerable salts
Prior art date
Application number
DK363080A
Other languages
Danish (da)
English (en)
Other versions
DK363080A (da
DK156069B (da
Inventor
Michael Allen Cook
Alan David Curzons
Robert Bennett Wilkins
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10507413&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK156069(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of DK363080A publication Critical patent/DK363080A/da
Priority to DK070884A priority Critical patent/DK157555C/da
Publication of DK156069B publication Critical patent/DK156069B/da
Application granted granted Critical
Publication of DK156069C publication Critical patent/DK156069C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK363080A 1979-08-24 1980-08-22 Anvendelse af tert.butylaminsaltet af clavulansyre som mellemprodukt ved fremstillingen af clavulansyre og farmaceutisk tolerable salte og estere deraf DK156069C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK070884A DK157555C (da) 1979-08-24 1984-02-15 Clavulansyresalt i form af et acetonesolvat og fremgangsmaade til fremstilling deraf.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7929544 1979-08-24
GB7929544 1979-08-24

Publications (3)

Publication Number Publication Date
DK363080A DK363080A (da) 1981-02-25
DK156069B DK156069B (da) 1989-06-19
DK156069C true DK156069C (da) 1989-12-04

Family

ID=10507413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK363080A DK156069C (da) 1979-08-24 1980-08-22 Anvendelse af tert.butylaminsaltet af clavulansyre som mellemprodukt ved fremstillingen af clavulansyre og farmaceutisk tolerable salte og estere deraf

Country Status (20)

Country Link
US (1) US4647659A (de)
EP (1) EP0026044B1 (de)
JP (2) JPS5634685A (de)
KR (1) KR860000343B1 (de)
AU (1) AU535198B2 (de)
CA (1) CA1157862A (de)
DE (1) DE3063683D1 (de)
DK (1) DK156069C (de)
ES (1) ES8106157A1 (de)
FI (1) FI67222C (de)
GR (1) GR69870B (de)
HK (1) HK1086A (de)
HU (1) HU185619B (de)
IE (1) IE50047B1 (de)
IL (1) IL60885A (de)
MY (1) MY8500999A (de)
NO (1) NO165241C (de)
NZ (1) NZ194703A (de)
PL (1) PL139811B1 (de)
ZA (1) ZA805206B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1000035B (el) * 1987-01-29 1990-03-12 Beecham Group Plc Κλαβουλανικο καλιο.
ES2010143A6 (es) 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
JPH0457085U (de) * 1990-09-14 1992-05-15
JPH0569557U (ja) * 1992-02-26 1993-09-21 東京電機工業株式會社 固体蓄熱装置
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
AT1447U1 (de) * 1992-06-11 1997-05-26 Smithkline Beecham Plc Neue salze von clavulansäure
AT475U1 (de) * 1992-06-11 1995-11-27 Smithkline Beecham Plc Verfahren zur herstellung von clavulansaeure
SI9300296B (sl) 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
GB2282810B (en) * 1992-06-11 1997-02-26 Smithkline Beecham Plc Preparation or purification of clavulanic acid
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
AT1446U1 (de) * 1992-10-31 1997-05-26 Smithkline Beecham Plc Verfahren zur herstellung und/oder reinigung von clavulansäure
GB9305565D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes
US5760218A (en) * 1993-03-26 1998-06-02 Gist-Brocades N.V. Diamine salts of clavulanic acid
RO112113B1 (ro) * 1993-03-26 1997-05-30 Gist Brocades Nv Saruri diaminice ale acidului clavulanic si procedeu pentru prepararea acestora
US5821364A (en) * 1993-03-26 1998-10-13 Gist-Brocades N.V. Diamine salts of clavulanic acid
DE4318916A1 (de) * 1993-06-07 1994-12-08 Bayer Ag Cyclobutylazole
ATE198892T1 (de) 1993-11-17 2001-02-15 Biochemie Gmbh Trennung von cephalosporinisomeren
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
GB9426261D0 (en) * 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
GB9500977D0 (en) * 1995-01-19 1995-03-08 Smithkline Beecham Plc Novel process
WO1996026944A1 (en) * 1995-02-25 1996-09-06 Spurcourt Limited Clavulanic acid salts
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
JPH09152148A (ja) * 1995-09-29 1997-06-10 Tokyo Denki Kogyo Kk 蓄熱式空調装置
US6414142B1 (en) 1996-06-13 2002-07-02 Smithkline Beecham Corporation Process for preparing potassium clavulanate
AT404728B (de) * 1996-11-27 1999-02-25 Biochemie Gmbh Verfahren zur herstellung von clavulansäure-aminsalzen
CA2336363A1 (en) * 1998-07-03 2000-01-13 Dsm N.V. Fermentation process to produce clavulanic acid at a low concentration of free amino acids
TR200100873T2 (tr) * 1998-09-29 2001-07-23 Dsm N.V. Klavülanik asitin kontrol edilen bir amonyak seviyesinde mayalanması
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
ES2177391B1 (es) * 2000-04-19 2004-08-16 Felipe Lopez Oliva Muñoz Protesis de disco cervical.
ES2225524T5 (es) 2000-05-13 2009-03-01 Smithkline Beecham Plc Procedimiento para la purificacion de una sal de acido clavulanico.
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法
CN109305978A (zh) * 2017-07-26 2019-02-05 山东睿鹰先锋制药有限公司 一种制备克拉维酸盐的新方法
CN108822134B (zh) * 2018-04-25 2021-06-25 国药集团威奇达药业有限公司 克拉维酸叔丁胺盐的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508977A (en) * 1974-04-20 1978-04-26 Beecham Group Ltd Beta-lactam antibiotic from streptomyces clavuligerus
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
YU40452B (en) * 1975-02-07 1986-02-28 Beecham Group Plc Process for the elimination of contaminating impurities from clavulinic acid
GB1543563A (en) * 1975-02-07 1979-04-04 Glaxo Lab Ltd Beta-lactam antibiotic in purified form
GB1578739A (en) * 1976-07-23 1980-11-05 Beecham Group Ltd Amine salts of clavulanic acid methods for their preparation and compositions containing them
GB1572912A (en) * 1977-01-19 1980-08-06 Beecham Group Ltd Clavulanic acid esters
US4255332A (en) * 1977-09-01 1981-03-10 Beecham Group Limited Process for the preparation of potassium clavulanate from lithium clavulanate

Also Published As

Publication number Publication date
NO165241C (no) 1991-01-16
KR830003492A (ko) 1983-06-20
PL226397A1 (de) 1981-05-22
PL139811B1 (en) 1987-02-28
IL60885A (en) 1983-11-30
HK1086A (en) 1986-01-10
ZA805206B (en) 1981-08-26
AU6163280A (en) 1981-04-09
NO802498L (no) 1981-02-25
AU535198B2 (en) 1984-03-08
DK363080A (da) 1981-02-25
MY8500999A (en) 1985-12-31
NO165241B (no) 1990-10-08
HU185619B (en) 1985-03-28
EP0026044A1 (de) 1981-04-01
ES494431A0 (es) 1981-07-16
FI802590A (fi) 1981-02-25
IE50047B1 (en) 1986-02-05
JPH02167286A (ja) 1990-06-27
FI67222C (fi) 1985-02-11
DE3063683D1 (en) 1983-07-14
DK156069B (da) 1989-06-19
JPH0234954B2 (de) 1990-08-07
JPH0415234B2 (de) 1992-03-17
FI67222B (fi) 1984-10-31
ES8106157A1 (es) 1981-07-16
EP0026044B1 (de) 1983-06-08
CA1157862A (en) 1983-11-29
GR69870B (de) 1982-07-20
JPS5634685A (en) 1981-04-06
NZ194703A (en) 1983-09-02
IL60885A0 (en) 1980-10-26
KR860000343B1 (ko) 1986-04-12
IE801777L (en) 1981-02-24
US4647659A (en) 1987-03-03

Similar Documents

Publication Publication Date Title
DK156069C (da) Anvendelse af tert.butylaminsaltet af clavulansyre som mellemprodukt ved fremstillingen af clavulansyre og farmaceutisk tolerable salte og estere deraf
SE7602317L (sv) 1,4-dihydropyridinkarbonsyraalkylestrar till anvendning som lekemedel och sett att framstella desamma
DK410781A (da) N-arylbenzamid-derivater og salte deraf fremgangsmaade til deres fremstilling og deres anvendelse som herbicider
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK148632C (da) Analogifremgangsmaade til fremstilling af hydroxykarbonylfosfonsyremonoestere eller optiske antipoder og/eller fysiologisk acceptable salte deraf
DK136781A (da) Diaminopyridiner og salte heraf fremgangsmaade til fremstillinng af disse og deres anvendelse som mellemprodukter
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK149610C (da) Analogifremgangsmaade til fremstilling af trh-analoge di- eller tripeptidamider eller terapeutisk acceptable komplekser eller salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK322380A (da) Fr&mgangsmaade til fremstilling af monacolin k salte eller estere
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK163427C (da) Saerlig fremgangsmaade til fremstilling af alfa-arylalkansyrer og salte heraf ved omlejring af alfa-halogenalkylarylketaler
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
SE7710637L (sv) Alkoxisubstituerade pyrimidinyltionofosfonsyraestrar till anvendning som insekticider och akaricider och sett att framstella foreningarna
DK255276A (da) Fremgangsmade til fremstilling af substituerede benzamider eller salte, oxider og optisk aktive isomere deraf
DK157136C (da) Fremgangsmaade til fremstilling af 6-beta-iodpenicillansyre og estre heraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK149854C (da) Analogifremgangsmaade til fremstilling af 1,2,4-oxadiazolin-5-oner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf samt mellemprodukter til anvendelse ved fremstillingen
DK165983C (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf
DK164169C (da) Analogifremgangsmaade til fremstilling af 7-alfa-methoxycephalosporiner eller farmaceutisk acceptable salte deraf samt et mellemprodukt til anvendelse herved
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK558283D0 (da) Spiro-3-heteroazolidindion-forbindelser og farmaceutisk acceptable salte deraf,farmaceutisk praeparat indeholdende saadanne forbindelser og mellemprodukter ved deres fremstilling
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
PUP Patent expired